Plain-English translation of NCT07919418 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Researchers are building a new type of laboratory test that uses your own cancer cells, immune cells, and surrounding tissue to create a personalized 3D model of your cancer. This model will help doctors understand why some colorectal cancers resist chemotherapy and find the best treatment plan for you specifically.
Current laboratory tests don't fully capture how complex colorectal cancer really is—they miss the interactions between cancer cells, the immune system, and surrounding tissue that affect whether treatments work. This trial aims to create better laboratory tools that can predict which patients will respond to which treatments, moving toward truly personalized medicine.
You likely qualify if…
You likely don't qualify if…
If you qualify, researchers will collect tissue and blood samples during or after your surgery and chemotherapy treatment. These samples will be used to build a personalized 3D model of your cancer in the laboratory. The study involves about 60 patients total, and your participation helps doctors develop better ways to predict treatment outcomes for future colorectal cancer patients.
AI-generated summary from trial data · Nov 17, 2026 · Not medical advice
China
Sponsor
Peking Union Medical College Hospital
Collaborators
Ningbo Medical Center Lihuili Hospital
Enrollment target
~60 participants
Started
May 2025
Primary completion
November 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yilei Mao, MD PHD
Peking Union Medical College Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.